- NEJM retracts pivotal data for Amgen's TavneosPivotal data for Amgen’s Tavneos have been retracted from the New England Journal of Medicine, creating another obstacle for the beleaguered autoimmune drug. Two academic authors requested the re…Endpoints · 25d ago↗ source
- John Reed on J&J’s R&D model, oncology deals and pipeline expansion potentialJohn Reed has overseen the pipelines of three of the largest drugmakers since leaving Southern California's Sanford Burnham medical research institute 13 years ago, giving him unique insight into h…Endpoints · 25d ago↗ source
- EU lobby urges member states to improve Europe’s life sciences sectorMore than 200 biopharma investors and firms have signed an open letter calling for European governments to improve Europe’s life sciences sector. The Friday letter was addressed to EU member stat…